NBIX logo

Neurocrine Biosciences (NBIX) Total liabilities

annual total liabilities:

$1.13B+$109.60M(+10.75%)
December 31, 2024

Summary

  • As of today (May 29, 2025), NBIX annual total liabilities is $1.13 billion, with the most recent change of +$109.60 million (+10.75%) on December 31, 2024.
  • During the last 3 years, NBIX annual total liabilities has risen by +$430.50 million (+61.63%).
  • NBIX annual total liabilities is now at all-time high.

Performance

NBIX Total liabilities Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherNBIXbalance sheet metrics

quarterly total liabilities:

$1.15B+$23.00M(+2.04%)
March 31, 2025

Summary

  • As of today (May 29, 2025), NBIX quarterly total liabilities is $1.15 billion, with the most recent change of +$23.00 million (+2.04%) on March 31, 2025.
  • Over the past year, NBIX quarterly total liabilities has increased by +$65.70 million (+6.05%).
  • NBIX quarterly total liabilities is now at all-time high.

Performance

NBIX quarterly total liabilities Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherNBIXbalance sheet metrics

Total liabilities Formula

Total Liabilities = Current Liabilities + Long-Term Liabilities

NBIX Total liabilities Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterly
1 y1 year+10.8%+6.0%
3 y3 years+61.6%+52.9%
5 y5 years+68.7%+74.1%

NBIX Total liabilities Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs low
3 y3-yearat high+70.8%at high+97.8%
5 y5-yearat high+85.5%at high+97.8%
alltimeall timeat high>+9999.0%at high>+9999.0%

NBIX Total liabilities History

DateAnnualQuarterly
Mar 2025
-
$1.15B(+2.0%)
Dec 2024
$1.13B(+10.8%)
$1.13B(+38.3%)
Sep 2024
-
$816.10M(+2.6%)
Jun 2024
-
$795.80M(-26.7%)
Mar 2024
-
$1.09B(+6.6%)
Dec 2023
$1.02B(+54.2%)
$1.02B(+20.5%)
Sep 2023
-
$846.10M(+11.3%)
Jun 2023
-
$760.10M(+12.6%)
Mar 2023
-
$675.30M(+2.2%)
Dec 2022
$660.90M(-5.4%)
$660.90M(+10.4%)
Sep 2022
-
$598.80M(+2.8%)
Jun 2022
-
$582.30M(-22.7%)
Mar 2022
-
$753.40M(+7.9%)
Dec 2021
$698.50M(+14.8%)
$698.50M(+4.1%)
Sep 2021
-
$671.30M(-0.9%)
Jun 2021
-
$677.20M(+5.7%)
Mar 2021
-
$640.80M(+5.3%)
Dec 2020
$608.50M(-9.1%)
$608.50M(-12.9%)
Sep 2020
-
$698.30M(+2.0%)
Jun 2020
-
$684.40M(+3.4%)
Mar 2020
-
$661.60M(-1.1%)
Dec 2019
$669.10M(+30.6%)
$669.10M(+10.5%)
Sep 2019
-
$605.42M(+3.8%)
Jun 2019
-
$583.15M(+6.3%)
Mar 2019
-
$548.45M(+7.0%)
Dec 2018
$512.39M(+15.0%)
$512.39M(+5.4%)
Sep 2018
-
$486.23M(+4.8%)
Jun 2018
-
$463.88M(+5.0%)
Mar 2018
-
$441.87M(-0.8%)
Dec 2017
$445.45M(+787.2%)
$445.45M(+4.8%)
Sep 2017
-
$424.98M(+3.9%)
Jun 2017
-
$408.85M(+868.3%)
Mar 2017
-
$42.22M(-15.9%)
Dec 2016
$50.21M(-0.2%)
$50.21M(+5.7%)
Sep 2016
-
$47.51M(-2.6%)
Jun 2016
-
$48.80M(+5.2%)
Mar 2016
-
$46.37M(-7.9%)
Dec 2015
$50.33M(+46.6%)
$50.33M(+10.6%)
Sep 2015
-
$45.49M(+2.8%)
Jun 2015
-
$44.27M(+2.8%)
Mar 2015
-
$43.05M(+25.4%)
Dec 2014
$34.33M(+0.2%)
$34.33M(+1.8%)
Sep 2014
-
$33.71M(+3.1%)
Jun 2014
-
$32.69M(+1.4%)
Mar 2014
-
$32.24M(-5.9%)
Dec 2013
$34.27M(-17.6%)
$34.27M(-6.6%)
Sep 2013
-
$36.67M(-5.5%)
Jun 2013
-
$38.80M(-0.4%)
Mar 2013
-
$38.97M(-6.3%)
Dec 2012
$41.61M(-46.9%)
$41.61M(-16.7%)
Sep 2012
-
$49.95M(-12.9%)
Jun 2012
-
$57.35M(-13.5%)
Mar 2012
-
$66.31M(-15.3%)
Dec 2011
$78.29M(-37.4%)
$78.29M(-14.2%)
Sep 2011
-
$91.28M(-10.4%)
Jun 2011
-
$101.85M(-8.2%)
Mar 2011
-
$111.00M(-11.3%)
Dec 2010
$125.08M
$125.08M(-6.2%)
DateAnnualQuarterly
Sep 2010
-
$133.29M(-6.6%)
Jun 2010
-
$142.63M(+125.8%)
Mar 2010
-
$63.16M(-5.5%)
Dec 2009
$66.86M(-17.9%)
$66.86M(-10.6%)
Sep 2009
-
$74.83M(-5.9%)
Jun 2009
-
$79.52M(-2.9%)
Mar 2009
-
$81.92M(+0.6%)
Dec 2008
$81.41M(-48.5%)
$81.41M(-43.5%)
Sep 2008
-
$144.09M(-1.2%)
Jun 2008
-
$145.83M(+0.4%)
Mar 2008
-
$145.22M(-8.1%)
Dec 2007
$157.96M(+110.7%)
$157.96M(+117.7%)
Sep 2007
-
$72.54M(-0.4%)
Jun 2007
-
$72.81M(+1.1%)
Mar 2007
-
$72.01M(-3.9%)
Dec 2006
$74.96M(-19.4%)
$74.96M(-3.5%)
Sep 2006
-
$77.66M(-3.9%)
Jun 2006
-
$80.77M(-13.7%)
Mar 2006
-
$93.57M(+0.6%)
Dec 2005
$93.02M(-25.8%)
$93.02M(-4.3%)
Sep 2005
-
$97.23M(-6.1%)
Jun 2005
-
$103.49M(-7.3%)
Mar 2005
-
$111.65M(-11.0%)
Dec 2004
$125.39M(-23.5%)
$125.39M(-10.5%)
Sep 2004
-
$140.06M(+3.8%)
Jun 2004
-
$134.94M(-11.1%)
Mar 2004
-
$151.86M(-7.3%)
Dec 2003
$163.84M(+287.5%)
$163.84M(-1.0%)
Sep 2003
-
$165.57M(+1.7%)
Jun 2003
-
$162.79M(+10.1%)
Mar 2003
-
$147.83M(+249.6%)
Dec 2002
$42.28M(+17.6%)
$42.28M(+8.9%)
Sep 2002
-
$38.81M(+13.7%)
Jun 2002
-
$34.14M(-0.6%)
Mar 2002
-
$34.35M(-4.5%)
Dec 2001
$35.96M(+58.0%)
$35.96M(+10.9%)
Sep 2001
-
$32.42M(+56.2%)
Jun 2001
-
$20.76M(+6.2%)
Mar 2001
-
$19.55M(-14.1%)
Dec 2000
$22.75M(+77.8%)
$22.75M(+53.5%)
Sep 2000
-
$14.82M(+34.1%)
Jun 2000
-
$11.05M(-23.0%)
Mar 2000
-
$14.36M(+12.2%)
Dec 1999
$12.80M(+50.6%)
$12.80M(+42.2%)
Sep 1999
-
$9.00M(+23.3%)
Jun 1999
-
$7.30M(+10.6%)
Mar 1999
-
$6.60M(-22.4%)
Dec 1998
$8.50M(-2.3%)
$8.50M(+3.7%)
Sep 1998
-
$8.20M(+60.8%)
Jun 1998
-
$5.10M(-16.4%)
Mar 1998
-
$6.10M(-29.9%)
Dec 1997
$8.70M(+67.3%)
$8.70M(+35.9%)
Sep 1997
-
$6.40M(-3.0%)
Jun 1997
-
$6.60M(+15.8%)
Mar 1997
-
$5.70M(+9.6%)
Dec 1996
$5.20M
$5.20M(+30.0%)
Sep 1996
-
$4.00M(-18.4%)
Jun 1996
-
$4.90M(+25.6%)
Mar 1996
-
$3.90M

FAQ

  • What is Neurocrine Biosciences annual total liabilities?
  • What is the all time high annual total liabilities for Neurocrine Biosciences?
  • What is Neurocrine Biosciences annual total liabilities year-on-year change?
  • What is Neurocrine Biosciences quarterly total liabilities?
  • What is the all time high quarterly total liabilities for Neurocrine Biosciences?
  • What is Neurocrine Biosciences quarterly total liabilities year-on-year change?

What is Neurocrine Biosciences annual total liabilities?

The current annual total liabilities of NBIX is $1.13B

What is the all time high annual total liabilities for Neurocrine Biosciences?

Neurocrine Biosciences all-time high annual total liabilities is $1.13B

What is Neurocrine Biosciences annual total liabilities year-on-year change?

Over the past year, NBIX annual total liabilities has changed by +$109.60M (+10.75%)

What is Neurocrine Biosciences quarterly total liabilities?

The current quarterly total liabilities of NBIX is $1.15B

What is the all time high quarterly total liabilities for Neurocrine Biosciences?

Neurocrine Biosciences all-time high quarterly total liabilities is $1.15B

What is Neurocrine Biosciences quarterly total liabilities year-on-year change?

Over the past year, NBIX quarterly total liabilities has changed by +$65.70M (+6.05%)
On this page